AI-driven tools, leveraging advanced data on developability properties, enable the precise characterization of antibodies and offer valuable insights into their suitability for therapeutic applications. Creative Biolabs offers an efficient and economical high-throughput antibody production service for AI-based antibody characterization to aid global customers in the discovery and development of potent and effective therapeutic antibodies.
Antibodies have emerged as a cornerstone of therapeutic drugs due to their high specificity and affinity for target molecules. The swift screening of antibodies through target binding and subsequent functional characterization is essential for identifying candidates suitable for clinical use. Traditional methods often suffer from being slow, labor-intensive, and costly. However, breakthroughs in artificial intelligence (AI) are streamlining the antibody development process, enhancing efficiency as well as reducing time and expense.
Fig.1 AI/ML-based antibody sequence design.1,2
Incorporating cutting-edge AI technologies, Creative Biolabs provides a comprehensive high-throughput antibody production service for AI-based antibody characterization to help centralize and streamline antibody production.
Based on our platform, our high-throughput antibody production service integrates AI technology to intelligently analyze massive antibody sequences, predict the structure, function, specificity, and affinity of antibodies, as well as efficiently characterize their dynamics, epitope, and other characteristics. According to the characterization results, the optimal antibody is selected for large-scale production. Throughout the process, our service greatly shortens the cycle of the antibody development process and reduces experimental costs and time costs. At the same time, we also provide high-throughput production services for tens of thousands of antibody sequences designed or optimized using AI, and efficiently complete the production of 1000+ recombinant antibodies within two weeks.
Furthermore, our comprehensive quality control system ensures that our entire process meets rigorous standards and is adaptable to a wide range of applications, particularly in the production of therapeutic antibodies. The antibodies we produce are ready for immediate experimental use, eliminating the need for further processing. At Creative Biolabs, the collaboration between biologists, data scientists, and engineers with solid expertise and project experience ensures that we can deliver satisfactory and high-quality results to our customers in a timely manner.
Our high throughput antibody production service for AI-based antibody characterization offers a seamless workflow from folding prediction to epitope mapping. This ensures the production of superior recombinant antibodies, meticulously optimized across all critical parameters to meet the highest quality standards.
Sa***r 5/Jul/2024
Label: Efficiency and High-quality
I recently employed the High Throughput Antibody Production Service for AI-based Antibody Characterization from Creative Biolabs, and I am thrilled with the results. The high throughput capability of this service is exceptional. The production phase was remarkably swift, significantly reducing our project's timeline without compromising on quality. The time saved here allowed us to expedite our research and focus on critical decision-making processes. Moreover, the AI-based characterization provided detailed insights into antibody specificity and affinity, enabling us to fine-tune our applications with precision.
If you are looking for a smarter high throughput antibody production service for AI-based antibody de novo design, please get in touch with us to make a discussion for further collaboration.
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.